Clinical Research Directory
Browse clinical research sites, groups, and studies.
Influence of an Anti-osteoporotic Drug on Healing After Surgical Repair of Chronic Rotator Cuff Lesions of the Shoulder
Sponsor: AUVA Traumazentrum Vienna Site UKH Meidling
Summary
This is a prospective, single-center, placebo-controlled, non-comparative, phase II study to evaluate the influence of an adjuvant, intravenous therapy with zoledronic acid (single dose) on healing after arthroscopic repair of chronic rotator cuff tears. The study including its financial support was approved by the medical director of the General Accident Insurance Institution (AUVA) , Dr. Roland Frank. Hypothesis to prove: Adjuvant intravenous therapy with zoledronic acid does improve tendon healing after arthroscopic reconstruction of chronic rotator cuff tears compared to a control group without adjuvant therapy with zoledronic acid.,
Official title: Influence of Zoledronic Acid on Healing After Arthroscopic Repair of Chronic Rotator Cuff Lesions - A Prospective, Randomized, Placebo-controlled Phase II Trial
Key Details
Gender
All
Age Range
50 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2022-08-22
Completion Date
2030-12
Last Updated
2024-03-18
Healthy Volunteers
No
Conditions
Interventions
Intravenous Infusion of Aclasta®
Intravenous Infusion of Aclasta® (Verum) or physiological saline solution 0.9% (Placebo)
Locations (1)
Jakob Schanda
Vienna, Austria